Neeraj Vinayakumar*

Department of Gastroenterology, Sriramakrishna Ashrama Charitable Hospital, Trivandrum, Kerala, India

*Corresponding Author: Neeraj Vinayakumar, Department of Gastroenterology, Sriramakrishna Ashrama Charitable Hospital, Trivandrum, Kerala, India.

Received: August 27, 2021; Published: October 01, 2021

Citation: Neeraj Vinayakumar. “COVID-19 Vaccination in Chronic Liver Disease". Acta Scientific Clinical Case Reports 5.11 (2021): 01.

Abstract

&nsp; Overall, more than 212 million cases of COVID-19 has been reported globally with nearly 4.5 million deaths [1]. WHO has identified those with chronic liver disease as a vulnerable group. Many of the patients with chronic liver disease go in for decompensation and acute on chronic liver failure after getting infected with COVID-19. It is seen not only immediately after COVID-19 infection but even months after getting cleared of the infection, the mechanism of which is yet to be understood.

Bibliography

1. WHO Coronavirus (COVID-19) Dashboard (2021).
2. Sharma A., et al. “COVID-19 Vaccines in Patients with Chronic Liver Disease”. Journal of Clinical and Experimental Hepatology (2021).
3. Fix OK., et al. “American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease”. Hepatology 2 (2021): 1049-1064.

Copyright: © 2021 Neeraj Vinayakumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.